These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11713824)

  • 1. European Union guidance on the quality, safety and efficacy of DNA vaccines and regulatory requirements.
    Robertson JS; Cichutek K
    Dev Biol (Basel); 2000; 104():53-6. PubMed ID: 11713824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European regulations relevant to the marketing and use of fish vaccines.
    Lee A
    Dev Biol Stand; 1997; 90():341-6. PubMed ID: 9270862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assuring the quality, safety, and efficacy of DNA vaccines.
    Robertson JS; Griffiths E
    Mol Biotechnol; 2001 Feb; 17(2):143-9. PubMed ID: 11395863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and review of DNA vaccine products.
    Smith HA
    Dev Biol (Basel); 2000; 104():57-62. PubMed ID: 11713825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulatory system in europe with special emphasis on allergen products.
    Lorenz AR; Luttkopf D; Seitz R; Vieths S
    Int Arch Allergy Immunol; 2008; 147(4):263-75. PubMed ID: 18648190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines: safety aspect assessment and regulation.
    Medjitna TD; Stadler C; Bruckner L; Griot C; Ottiger HP
    Dev Biol (Basel); 2006; 126():261-70; discussion 327. PubMed ID: 17058502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of good clinical practice in the EEC and in Germany.
    Anhalt E
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):217-22. PubMed ID: 8361258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Viral safety: European and French directives].
    Rossi F; Legras JF
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S55-61. PubMed ID: 10896992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011.
    Bilbault P; Belorgey C; Zannad F; Golinelli D; Pletan Y;
    Therapie; 2010; 65(4):301-8, 291-9. PubMed ID: 20854751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Note for guidance. Production and quality control of cytokine products derived by biotechnological processes. Committee for Proprietary Medicinal Products: Ad hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
    Biologicals; 1991 Apr; 19(2):125-31. PubMed ID: 1888491
    [No Abstract]   [Full Text] [Related]  

  • 11. Assuring the quality, safety, and efficacy of DNA vaccines.
    Robertson JS; Griffiths E
    Methods Mol Med; 2006; 127():363-74. PubMed ID: 16988466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Note for guidance. Production and quality control of human monoclonal antibodies. Committee for Proprietary Medicinal Products: Ad hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.
    Biologicals; 1991 Apr; 19(2):133-8. PubMed ID: 1888492
    [No Abstract]   [Full Text] [Related]  

  • 13. Status of the GCP guidelines in Europe.
    Geussenhainer S
    Methods Find Exp Clin Pharmacol; 1993 May; 15(4):223-8. PubMed ID: 8361259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
    Tomić S; Sucić AF; Martinac AI
    Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy bio-safety: scientific and regulatory issues.
    Gonin P; Buchholz CJ; Pallardy M; Mezzina M
    Gene Ther; 2005 Oct; 12 Suppl 1():S146-52. PubMed ID: 16231047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA
    Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory framework of immunologicals in the European Union.
    Sauer F
    Biologicals; 1994 Dec; 22(4):307-11. PubMed ID: 7779353
    [No Abstract]   [Full Text] [Related]  

  • 19. Authorisation within the European Union of vaccines against antigenically variable viruses responsible for major epizootic diseases.
    Mackay DK
    Rev Sci Tech; 2007 Aug; 26(2):421-8. PubMed ID: 17892162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.